持股变动声明
Exagen(XGN)05-17 08:05
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000052 Size: 5 KB 网页链接
简介：Exagen Inc.成立于2002年。Exagen致力于通过及时鉴别诊断和优化治疗干预，改变患有衰弱和慢性自身免疫疾病的患者的护理连续体。该公司的目标是通过鉴别诊断，预后和监测复杂的自身免疫和自身免疫相关疾病（包括SLE和类风湿性关节炎或RA），使风湿病学家能够改善对患者的护理。
| 今开：1.94 | 昨收：1.935 |
| 最高：1.9649 | 最低：1.9 |
| 涨停价： | 跌停价： |
| 总市值：33530820 |
Exagen(XGN)05-17 08:05
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000052 Size: 5 KB 网页链接
Exagen(XGN)05-13 21:35
$Exagen(XGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001274737-24-000048 Act: 34 Size: 4 MB 网页链接
Exagen(XGN)06-13 04:15
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000062 Size: 5 KB 网页链接
Exagen(XGN)04-26 20:35
$Exagen(XGN)$ DEF 14A Other definitive proxy statements Accession Number: 0001274737-24-000028 Act: 34 Size: 1 MB 网页链接
Exagen(XGN)04-26 21:25
$Exagen(XGN)$ ARS Annual Report to Security Holders Accession Number: 0001274737-24-000037 Act: 34 Size: 13 MB 网页链接
Exagen(XGN)05-13 20:05
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-24-000045 Act: 34 Size: 300 KB 网页链接
Exagen(XGN)06-13 04:15
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000061 Size: 5 KB 网页链接
Exagen(XGN)06-12 04:15
$Exagen(XGN)$ 8-K Current report, item 5.07 Accession Number: 0001274737-24-000056 Act: 34 Size: 159 KB 网页链接
Exagen(XGN)04-26 20:35
$Exagen(XGN)$ 8-K Current report, items 5.02, 8.01, and 9.01 Accession Number: 0001274737-24-000030 Act: 34 Size: 188 KB 网页链接
Exagen(XGN)06-13 04:15
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000063 Size: 5 KB 网页链接
蹊之美股生物医药2021-08-12 03:35
作者：林出
微信公众号：蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
$Exagen(XGN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001274737-24-000067 Size: 9 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000068 Size: 5 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000061 Size: 5 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000062 Size: 5 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000063 Size: 5 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000064 Size: 5 KB 网页链接
$Exagen(XGN)$ 8-K Current report, item 5.07 Accession Number: 0001274737-24-000056 Act: 34 Size: 159 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000052 Size: 5 KB 网页链接
$Exagen(XGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001274737-24-000048 Act: 34 Size: 4 MB 网页链接
$Exagen(XGN)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001274737-24-000050 Act: 33 Size: 132 KB 网页链接